$10M sweet spot round size
Most of their 8 investments are in rounds between $5.5M and $76M
2019
Zenas BioPharma raised $118M on November 7, 2022
Investors: -, Longitude Capital, Xencor, Vivo Capital, Quan Capital 泉创资本, Perceptive Advisors, Wellington Management and Tellus BioVentures
viTToria biotherapeutics raised $10M on June 7, 2022
Investors: SV Life Sciences, Agent Capital and Tellus BioVentures
Dianthus Therapeutics, Inc. raised $100M on April 19, 2022
Investors: 5AM Ventures, Avidity Partners, Wedbush Securities and Tellus BioVentures
Navrogen raised $3M on August 9, 2021
Investors: Tellus BioVentures
Interius BioTherapeutics raised $76M on May 18, 2021
Investors: Knollwood Investment Advisory, Quan Capital 泉创资本, Longwood Fund, Logos Global Management, LP, RA Capital Management, L.P., Osage University Partners (OUP) and Tellus BioVentures
Zenas BioPharma raised undisclosed on March 23, 2021
Investors: Quan Capital 泉创资本, Wellington Management and Tellus BioVentures
Aegle Therapeutics raised $6.5M on September 29, 2020
Investors: New World Angels, DEFTA Partners, Ocean Azul Partners, FAN Fund and Tellus BioVentures
Interius BioTherapeutics raised $5.5M on March 13, 2020
Investors: Agent Capital and Tellus BioVentures